Medical Health & Life Science Research News

Continuous renal replacement therapy market worth 1.53 billion USD by 2022

The Continuous Renal Replacement Therapy (CRRT) Market is projected to reach USD 1.53 Billion by 2022 from USD 1.09 Billion in 2017, at a CAGR of 7.0%.

- Advertising -

Browse 65 Market Data Tables and 51 Figures spread through 188 Pages and in-depth TOC on "Continuous Renal Replacement Therapy (CRRT) Market"

www.marketsandmarkets.com/Market-R…m_campaign=PaidPR

This report analyzes and studies the major drivers, restraints, opportunities, and challenges of the CRRT market in North America, Europe, Asia-Pacific, and the Rest of the World (RoW). Factors such as increasing global incidence of acute kidney injury, increasing incidence of sepsis, growing prevalence of diabetes, and hypertension are driving the growth of the market.

Disposables product segment poised to grow fastest in CRRT market 

On the basis of product, the CRRT market is segmented into CRRT systems, disposables, and dialysates & replacement fluids. The disposables segment is expected to register highest CAGR during the forecast period mainly due to the large and regular demand for consumables owing to their short work life.

- Advertising -

Download PDF Brochure: www.marketsandmarkets.com/pdfdownl…m_campaign=PaidPR

Continuous venovenous hemodiafiltration (CVVHDF) segment is expected to register fastest growth rate during the forecast period 

Based on modality, the CRRT market is segmented into slow continuous ultrafiltration (SCUF), continuous venovenous hemofiltration (CVVH), continuous venovenous hemodialysis (CVVHD), and continuous venovenous hemodiafiltration (CVVHDF). CVVHDF segment is projected to register the highest CAGR due to benefits of convection and diffusion for the removal of solutes (which combines filtration and dialysis processes for the removal of small to medium-sized molecules).

Talk To Our Research Analysts: www.marketsandmarkets.com/speaktoa…m_campaign=PaidPR

Europe is estimated to account for the largest share of the CRRT market 

Geographically, the Continuous Renal Replacement Therapy (CRRT) Market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. Asia-Pacific is expected to grow at the highest CAGR during the forecast period due to the increasing incidence of acute kidney injuries.

The major players in the market are Baxter International Inc. (U.S.), Fresenius Medical Care AG & Co.

KGaA (Germany), Nikkiso Co., Ltd. (Japan), B. Braun Melsungen AG (Germany), Bellco S.r.l.

(Italy), NxStage Medical, Inc. (U.S.), Asahi Kasei Corporation (Japan), Infomed SA (Switzerland), Medica S.p.A. (Italy), and Toray Medical Co., Ltd.

(Japan).

News From

MarketsandMarkets™ - Business ResearchMarketsandMarkets™
Category: Market Research Publishers and RetailersCompany profile: MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions. Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth ...